PharmTech LCGC Sciex Webinar 11.10
|Articles|November 1, 2008

Researchers Discover Sex Hormone-Binding Globulin Shows Link to Fracture Risk in Older Men

Researchers from the University of Gothenburg and other sites in Sweden, along with researchers from Portland, Oregon and Quebec, Canada conducted a study to examine the role of serum sex steroids in fracture risk among men.

Researchers from the University of Gothenburg and other sites in Sweden, along with researchers from Portland, Ore. and Quebec, conducted a study to examine the role of serum sex steroids in fracture risk among men. The study included 2,639 men with a mean age of 75 years from MrOS Sweden, a prospective, population-based cohort. The researchers used a specific gas chromatography–mass spectrometry technique to analyze sex steroids at baseline. After baseline, the incidence of at least one fracture was 20.9 per 1,000 person-years. The researchers found an inverse relationship between fracture risk and estradiol (HR per standard deviation decrease=1.34), free estradiol (HR per SD decrease=1.41), testosterone (HR per SD decrease=1.27), and free testosterone (HR per SD decrease=1.32). However, sex hormone–binding globulin was directly related to fracture risk (HR per SD decrease=1.41), according to the researchers.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.